ebselen (SPI-1005) / Sound Pharma 
Welcome,         Profile    Billing    Logout  
 9 Diseases   5 Trials   5 Trials   391 News 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ebselen (SPI-1005) / Sound Pharma
STOPMD-3, NCT04677972: SPI-1005 for the Treatment of Meniere's Disease

Completed
3
254
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Meniere Disease, Ménière
09/23
07/24
NCT06859788: SPI-1005 for the Treatment of Meniere's Disease (Open Label)

Not yet recruiting
3
200
US
Ebselen, SPI-1005
Sound Pharmaceuticals, Incorporated
Meniere's Disease, Ménière's Disease
10/26
10/26
2015-000323-86: Ebselen as an add-on treatment in hypo/mania

Not yet recruiting
2
60
Europe
SPI-1005, Ebselen, NA, Capsule
University of Oxford, The Stanley Medical Research Institute
Patients with bipolar disorder meeting DSM-5 criteria for hypomania or mania, Bipolar disorder is characterised by periods of elevated mood and periods of depression. The elevated mood is known as hypomania or mania: an individual feels abnormally happy, energetic or irritable., Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
NCT02819856: SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Completed
2
40
US
Placebo, SPI-1000, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Low Dose, SPI-1005 Ebselen 200mg Capsule x2, SPI-1005 Mid Dose, SPI-1005 Ebselen 200mg Capsule x3, SPI-1005 High Dose
Sound Pharmaceuticals, Incorporated, Medical University of South Carolina, Cystic Fibrosis Foundation
Ototoxicity
04/23
04/23
NCT04483973: SPI-1005 Treatment in Severe COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Coronavirus, Coronavirus Infection, Corona Virus Infection
12/23
12/23
NCT04484025: SPI-1005 Treatment in Moderate COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Corona Virus Infection, Coronavirus, Coronavirus Infection
12/23
12/23
NCT06340633: SPI-1005 in Adults Receiving Cochlear Implant

Not yet recruiting
2
40
NA
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated, Med-El Corporation
Hearing Loss, Cochlear Trauma
12/25
12/25
OxIMP, NCT05117710: IMPase in Treatment-resistant Depression

Recruiting
1
50
Europe
Ebselen, SPI-1005, PZ-51, Ebselene, Ebselenum, Ebseleno, Harmokisane, Placebo, Dummy
University of Oxford, Medical Research Council, Sound Pharmaceuticals, Incorporated
Depressive Disorder, Treatment-Resistant
05/24
05/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ebselen (SPI-1005) / Sound Pharma
STOPMD-3, NCT04677972: SPI-1005 for the Treatment of Meniere's Disease

Completed
3
254
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Meniere Disease, Ménière
09/23
07/24
NCT06859788: SPI-1005 for the Treatment of Meniere's Disease (Open Label)

Not yet recruiting
3
200
US
Ebselen, SPI-1005
Sound Pharmaceuticals, Incorporated
Meniere's Disease, Ménière's Disease
10/26
10/26
2015-000323-86: Ebselen as an add-on treatment in hypo/mania

Not yet recruiting
2
60
Europe
SPI-1005, Ebselen, NA, Capsule
University of Oxford, The Stanley Medical Research Institute
Patients with bipolar disorder meeting DSM-5 criteria for hypomania or mania, Bipolar disorder is characterised by periods of elevated mood and periods of depression. The elevated mood is known as hypomania or mania: an individual feels abnormally happy, energetic or irritable., Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
NCT02819856: SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Completed
2
40
US
Placebo, SPI-1000, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Low Dose, SPI-1005 Ebselen 200mg Capsule x2, SPI-1005 Mid Dose, SPI-1005 Ebselen 200mg Capsule x3, SPI-1005 High Dose
Sound Pharmaceuticals, Incorporated, Medical University of South Carolina, Cystic Fibrosis Foundation
Ototoxicity
04/23
04/23
NCT04483973: SPI-1005 Treatment in Severe COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Coronavirus, Coronavirus Infection, Corona Virus Infection
12/23
12/23
NCT04484025: SPI-1005 Treatment in Moderate COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Corona Virus Infection, Coronavirus, Coronavirus Infection
12/23
12/23
NCT06340633: SPI-1005 in Adults Receiving Cochlear Implant

Not yet recruiting
2
40
NA
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated, Med-El Corporation
Hearing Loss, Cochlear Trauma
12/25
12/25
OxIMP, NCT05117710: IMPase in Treatment-resistant Depression

Recruiting
1
50
Europe
Ebselen, SPI-1005, PZ-51, Ebselene, Ebselenum, Ebseleno, Harmokisane, Placebo, Dummy
University of Oxford, Medical Research Council, Sound Pharmaceuticals, Incorporated
Depressive Disorder, Treatment-Resistant
05/24
05/24

Download Options